-+ 0.00%
-+ 0.00%
-+ 0.00%

Akebia Therapeutics announces annual shareholder meeting via webcast

PUBT·04/15/2026 20:10:45
Listen to the news
Akebia Therapeutics announces annual shareholder meeting via webcast
  • Akebia Therapeutics schedules 2026 annual stockholder meeting in virtual format for June 17, 2026.
  • Shareholders will vote on electing three Class III directors: Adrian Adams, Michael Rogers, LeAnne M. Zumwalt.
  • Ballot includes proposal to increase authorized shares of capital stock to 525,000,000, including common stock to 500,000,000.
  • Advisory votes cover named executive officer compensation plus preferred frequency for future say-on-pay votes.
  • Meeting agenda also includes ratification of Ernst & Young as independent registered public accounting firm for fiscal 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akebia Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001517022-26-000029), on April 15, 2026, and is solely responsible for the information contained therein.